January, 2021

FDA Says Data Does Not Support Changes to COVID-19 Vaccine Doses

XTalks

The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature.

J&J says single dose of coronavirus vaccine 66% effective in large trial

Bio Pharma Dive

The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating

Trials 273
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Over-the-Counter Nasal Spray Could Be Effective Against COVID-19

BioSpace

An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient

And just like that, the goodwill is gone

World of DTC Marketing

THOUGHT: The reports of “pharma goodwill” were premature.

Sales 180

Navigating the Global NHP Shortage: How to Keep Your Development Program on Track

Camargo

In the first half of 2020 and as a direct consequence of the ongoing pandemic, China issued a ban on the export of non-human primates (NHPs) , including those used for pharmaceutical research.

How to harness artificial intelligence to boost business and make our world more human

Scienmag

Welcome to the World of Hyperautomation Credit: World Scientific Two centuries ago, the Industrial Revolution began to automate “blue-collar” work, allowing higher profits and wider societal improvements like the reduction of famine and the increase in living standards.

Parkinson’s Disease: How close are we to a cure?

Delveinsight

Neurological disorders are the leading source of disability globally, and Parkinson’s is the fastest-growing neurological condition.

More Trending

Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses

NY Times

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.

10 Essential pharma content strategy must-haves

World of DTC Marketing

SUMMARY: Pharma has not embraced a content strategy when the number of online health seekers is climbing. A content management strategy can lead to a better brand-patient relationship and turn customers into brand ambassadors. I’m not a huge believer in content strategy for CPGs.

A new approach to COVID-19 treatment

Pharma Phorum

While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus.

Ukraine genome survey adds missing pieces to human diversity puzzle

Scienmag

International Ukraine Genetic Diversity Project finds a quarter of the genetic variation in Europe, dramatically increasing information on population diversity and medical genetic variation Credit: Oakland University Today, the largest study of genetic diversity in Ukraine was published in the open science journal GigaScience.

WHO weighs in on COVID-19 vaccine second dose delay

BioPharma Reporter

The World Health Organizationâs vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations. Markets & Regulations

Vaccine makers prepare response as coronavirus mutations raise alarms

Bio Pharma Dive

So far, both Pfizer's and Moderna's vaccines appear to work against more transmissible variants, but preparation is underway for the day they don't

Alzheimer’s Drug Shows Promise in Small Trial

NY Times

Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say. Alzheimer's Disease Clinical Trials Drugs (Pharmaceuticals) Brain Eli Lilly and Company donanemab

Trials 113

Covid vaccine profits and the strain on supply channels

World of DTC Marketing

SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others.

Neurology’s Growing Need for Disposable Technologies

Pharma Mirror

By Boris Goldstein, Co-Founder & Executive Chairman at Brain Scientific COVID-19 is known for its impacts on a patient’s respiratory system, but it has also been found to affect individuals in unique ways and with varying severity levels depending on their age, risk factors, and comorbidities.

In ED patients with chest and abdominal pain, care delivered by physicians and APPs is similar

Scienmag

Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM.

UK left trailing as EU quickly approves Moderna’s COVID-19 vaccine

Pharma Phorum

The European Union has approved the coronavirus vaccine from Moderna, leaving the UK trailing because of changes to post-Brexit drug approval rules.

Sanofi, in unusual move, to help Pfizer, BioNTech make coronavirus vaccine doses

Bio Pharma Dive

The French drugmaker, having hit delays with its own coronavirus shot, agreed to manufacture over 100 million doses of Pfizer and BioNTech's vaccine for supply in Europe

NeuroRx on the Move: An Interview with Founder and CEO Jonathan Javitt

BioSpace

Like many biopharma companies, the global COVID-19 pandemic has caused delays while also offering opportunities for NeuroRx

109
109

The future of pharma depends on its employees

World of DTC Marketing

MINUTE READ: Big pharma should take a good, hard look at small biotech companies and try to better understand how they succeed and are able to make strategic decisions faster without multi-levels of bureaucracy.

HR 169

5 Trends That Will Shape Pharma Marketing in 2021

Pharma Marketing Network

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021.

Scientists publish a blueprint to apply artificial intelligence to extend human longevity

Scienmag

Bad news for Pfizer as blockbuster Xeljanz flunks safety study

Pharma Phorum

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety has achieved the opposite.

Drugs 107

5 FDA approval decisions to watch in the 1st quarter

Bio Pharma Dive

By March, the FDA expects to conclude reviews of key drugs for heart failure, Duchenne's and multiple myeloma, as well as decide on whether to clear Biogen's controversial Alzheimer's treatment

Are Gene Therapies the Medicine of the Future?

BioSpace

Gene therapies offer great reward in the form of treating various devastating diseases, but there are also significant risks

Help Wanted: New breed of pharma CEOs

World of DTC Marketing

SUMMARY: The argument that the first rule of business is to make money is becoming more irrelevant in a time of social chaos. Every company is entitled to make a profit, but when a CEO earns $28 million a year, and can’t afford medications, something is dreadfully wrong.

Colorado RFP on Drug Importation Accounts for Canada’s Order Protecting Against Shortages

Pharmacy Checkers

This week, the Colorado Department of Health Care Policy and Financing issued a request for proposals, called an Invitation to Negotiate, to operate a state wholesale drug importation program as permitted under federal law and the administrative final rule issued by HHS last year, referred to as the Section 804 rule.

Peer-reviewed report on Moderna COVID-19 vaccine publishes

Scienmag

Data from Phase 3 clinical trial confirm vaccine is effective Credit: NIH WHAT: The investigational vaccine known as mRNA-1273 was 94.1%

Allergic reactions prompt Moderna COVID vaccine pause in California

Pharma Phorum

Public health authorities in California are seeking a halt on dosing of one lot of Moderna’s COVID-19 vaccine after reports of allergic reactions at one immunisation clinic.

Ten key clinical trials to watch in the first half of 2021

Bio Pharma Dive

Study results could come soon for several coronavirus vaccines, as well as experimental medicines from Amgen, Vertex and Sage Therapeutics

Biotech In-Demand Jobs: Project Managers

BioSpace

Project managers in the biotech industry play an especially important role on a daily basis

107
107

Are we heading towards Medicare for all?

World of DTC Marketing

IN SUMMARY: The Democrats control the Senate now, A poll last April shows that 69 percent of registered voters support Medicare for All, a plan that would create a national health insurance plan available for all Americans. The poll was conducted by the Washington, D.C.

Boehringer Ingelheim announces partnership with Google

Pharma Times

Partnership will aim to research and implement quantum computing in pharma R&D

Honeybees reveal how our floral landscape has changed over the last 65 years

Scienmag

Honeybees have been helping researchers from the National Botanic Garden of Wales track how the UK’s fields, hedgerows, wild spaces and gardens have changed since the 1950s.

What we’re expecting in 2021, and beyond…

Pharma Phorum

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year.

Celgene's cell therapy spinout nets $292M from blank-check merger

Bio Pharma Dive

With additional financing, Celularity will have $372 million to back development of experimental off-the-shelf treatments for cancer and autoimmune diseases